Dataset_NephroLongCovid_figshare.xlsx

The aim of this study was to identify ME/CFS patients among Long-Covid patients with elevated autoantibodies. In 7 cases plasmapheresis (PE) and intravenous immunoglobulins (IVIG) with repetitive autoantibody-measurements were applied: 4 PE sessions on day 1, 5, 30 and 60 and a low-dose IVIG therapy after each treatment. Antibodies were measured before the first PE, and two weeks after the last PE session. To monitor clinical outcomes, somatic and psychometric follow-up assessments were conducted before the first PE, 2 weeks after the second, and 2 weeks after the last PE: Schellong test, ISI (insomnia), FSS (fatigue), HADS (depression and anxiety), and EQ-5D-5L (quality of life) questionnaires.